The patient cohort selected for enrichment of CD4 + leukocytes included 30 male participants from the Epidemiology for health study (EpiHealth) and 2 males from the Uppsala-Umeå Comprehensive Cancer Consortium (UCAN). This evidence concerns the gene CD4 and cancer.